{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:20:37Z","timestamp":1777612837847,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.brainres.2004.09.046","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T17:09:28Z","timestamp":1099501768000},"page":"66-73","source":"Crossref","is-referenced-by-count":50,"title":["Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice"],"prefix":"10.1016","volume":"1030","author":[{"given":"Hiroyuki","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumiko","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2004.09.046_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(99)02438-5","article-title":"S-100\u03b2 protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5-HT1A-receptor agonist Bay x 3702","volume":"858","author":"Ahlemeyer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.09.046_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","article-title":"Neuroprotective effect of riluzole in MPTP-treated mice","volume":"918","author":"Araki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.09.046_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0924-977X(01)00077-3","article-title":"Nitric oxide synthase inhibitors cause motor deficits in mice","volume":"11","author":"Araki","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2004.09.046_bib4","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2004.09.046_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X","article-title":"Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism","volume":"16","author":"Chao","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2004.09.046_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0892-0362(94)00048-I","article-title":"Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum","volume":"17","author":"Francis","year":"1995","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.brainres.2004.09.046_bib7","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/S0021-9258(17)41844-8","article-title":"Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridium and 4-phenylpyridine analogs in inner membrane preparation","volume":"269","author":"Gluck","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2004.09.046_bib8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.09.046_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2004.09.046_bib10","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1046\/j.1471-4159.1997.69062294.x","article-title":"S100\u03b2 induces neuronal cell death through nitric oxide release from astrocytes","volume":"69","author":"Hu","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.09.046_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00411-2","article-title":"Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(\u2212)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease","volume":"208","author":"Kato","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2004.09.046_bib12","first-page":"2108","article-title":"Inhibitory effect of ONO-2506 on GABAA receptor disappearance in cultures astrocytes and ischemic brain","volume":"25","author":"Katsumata","year":"1999","journal-title":"Abst. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1460-9568.1999.00421.x","article-title":"Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-induced ataxia: evidence from 6-subunit-deficient mice","volume":"11","author":"Korpi","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.09.046_bib15","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2004.09.046_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00004647-200206000-00010","article-title":"Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: Enhanced astrocytic synthesis of S-100\u03b2 in the periinfarct area precedes delayed infarct expansion","volume":"22","author":"Matsui","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2004.09.046_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2004.09.046_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.10225","article-title":"The Expression of S100 protein is related to neuronal damage in MPTP-treated Mice","volume":"42","author":"Muramatsu","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2004.09.046_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N","article-title":"Production of nitric oxide by glial cells: regulation and potential roles in the CNS","volume":"29","author":"Murphy","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2004.09.046_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00004647-200007000-00003","article-title":"High susceptibility to cerebral ischemia in GFAP-null mice","volume":"20","author":"Nawashiro","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2004.09.046_bib21","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2004.09.046_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-8993(90)91526-M","article-title":"Jr., Characterization of the origins of astrocyte response to injury using the 1-methyl-4-phenyl-1,2,3,6-tetrahtdropyridine","volume":"521","author":"O'Callaghan","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.09.046_bib23","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxocity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2004.09.046_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0166-2236(97)01139-9","article-title":"Reactive astrocytes: cellular and molecular cues to biological function","volume":"20","author":"Ridet","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib26","first-page":"984","article-title":"ONO-2506, a novel astrocyte modulating agent, suppresses the increase of COX-2 and iNOS mRNA expression in cultured astrocytes and ischemic brain","volume":"24","author":"Shimoda","year":"1998","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib27","first-page":"984","article-title":"ONO-2506 ameliorates neurodegeneration through inhibition of reduction of GLT-1 expression","volume":"24","author":"Shinagawa","year":"1998","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib28","first-page":"2108","article-title":"Modulating effects of ONO-2506 on astrocytic activation in cultured astrocytes from rat cerebrum","volume":"25","author":"Shinagawa","year":"1999","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.brainres.2004.09.046_bib29","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1177\/38.11.2212623","article-title":"An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4)","volume":"38","author":"Streit","year":"1990","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.brainres.2004.09.046_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00004647-200206000-00011","volume":"22","author":"Tateishi","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2004.09.046_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2004.09.046_bib32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304016063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304016063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T15:18:25Z","timestamp":1624807105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899304016063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0006899304016063"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2004.09.046","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}